Table 1.
Ref. | λ1 | λ2 | λ3 | MD | FA | λ1–λ3 |
---|---|---|---|---|---|---|
Noam Nissan et al. [76] in pregnancy-associated breast cancer |
1.17 ± 0.11 | 0.95 ± 0.11 | 0.74 ± 0.11 | 0.95 ± 0.11 | 0.25 ± 0.05± | 0.43 ± 0.07 |
Haran et al. [79] (median % change responders) |
55.7 (43.6–77) |
55.4 (42.3–74.2) |
61.5 (41.3–81.0) |
55.6 (42.4–71.8) |
1.3 (214.3–20.8) |
55.4 (42.4–100.1) |
Onaygil et al. [78] | 1.91 ± 0.30 * 1.27 ± 0.19 ** |
1.68 ± 0.28 * 1.01 ± 0.20 ** |
1.46 ± 0.27 * 0.81 ± 0.24 ** |
1.68 ± 0.27 * 1.03 ± 0.19 ** |
0.14 ± 0.05 * 0.24 ± 0.14 ** |
0.45 ± 0.17 * 0.48 ± 0.25 ** |
λ1, λ2, λ3: eigenvalues, MD: mean diffusivity, FA: fractional anisotropy, λ1–λ3: empirical difference, ADC: apparent diffusion coefficient, *: benign, **: malignant.